A major contributor to this article appears to have a close connection with its subject. (April 2024) |
Flemming Ørnskov (born 24 January 1958) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma[3] since October 2019.
Flemming Ørnskov | |
|---|---|
 | |
| Born | 24 January 1958[1] |
| Alma mater | University of Copenhagen INSEAD Harvard University |
| Occupation(s) | CEO, Galderma |
| Children | 4 |
He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel.[4] He previously worked for Bayer, Bausch & Lomb and Novartis.[3]
He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017.[5][6]
Ørnskov was educated at the Esbjerg Gymnasium.[1] He received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.[7] Ørnskov is qualified as a doctor in Denmark and has experience as a practicing hospital physician.[8]
Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017.[9][10] He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline.[11]
Ørnskov is married to a German management consultant, with whom he has three sons and a daughter.[2][1]
Awards
editTop 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review[12]
Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech[13]
References
edit- ^ a b c Goodman, Matthew (28 April 2013). "Dane who won't make a drama out of a drugs giant". The Sunday Times.
- ^ a b Ward, Andrew (15 February 2015). "Monday interview: Flemming Ornskov, Shire CEO". Financial Times.
- ^ a b Liu, Angus (October 8, 2019). "Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after $10B Nestlé spinout". Fiercepharma.
- ^ "Shire chief finds right prescription for growth". The Telegraph. 29 December 2013. Retrieved 20 March 2014.
- ^ "Conseil d'administration : Waters". www.waters.com. Retrieved 2021-04-01.
- ^ "Waters Corporation Elects Flemming Ornskov to Board of Directors". Business Wire. June 2, 2017. Retrieved June 21, 2024.
- ^ "Executive Profile: Flemming Ornskov". Bloomberg. Retrieved 4 September 2017.
- ^ Clark, Andrew (26 April 2014). "Manifesto: maintaining a state of independence could be just what the doctor ordered". The Times.
- ^ Swetha Gopinath and Allegra Catelli (2024-03-22). "Galderma Surges in Debut, Bolstering Europe IPO Recovery". www.bloomberg.com. Retrieved 2024-06-14.
- ^ "GALDERMA STOCK SURGES IN DEBUT ON SWISS STOCK EXCHANGE SIX". Beauty Matter. 2024-03-22. Retrieved 2024-06-14.
- ^ "EQT's Galderma Seeks to Raise $2.3 Billion in Swiss Listing". The Business of Fashion. 2024-03-07. Retrieved 2024-06-14.
- ^ "The 'best-performing' CEO in the world is a pharma chief". BioPharma Dive. Retrieved 2021-04-01.
- ^ "The 25 most influential people in biopharma today - 2013". FierceBiotech. Retrieved 2021-04-01.
  | This Danish biographical article is a stub. You can help Wikipedia by expanding it. |
 | This business-related biographical article is a stub. You can help Wikipedia by expanding it. |